Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease

Cristina Bezzio; Gianluca Franchellucci; Edoardo V Savarino; Mauro Mastronardi; Flavio Andrea Caprioli; Giorgia Bodini; Angela Variola; Franco Scaldaferri; Federica Furfaro; Emma Calabrese; Maria Beatrice Principi; Giuseppe Biscaglia; Manuela Marzo; Andrea Michielan; Carolina Cavalli; Annalisa Aratari; Michele Campigotto; Linda Ceccarelli; Maria Cappello; Simone Saibeni; Paola Balestrieri; Alessandra Soriano; Valentina Casini; Lorenzo Bertani; Brigida Barberio; Francesco Simone Conforti; Silvio Danese; Alessandro Armuzzi

doi:10.1093/crocol/otae060

Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease

Cristina Bezzio
, Gianluca Franchellucci
, Edoardo V Savarino
, Mauro Mastronardi
, Flavio Andrea Caprioli
, Giorgia Bodini
, Angela Variola
, Franco Scaldaferri
, Federica Furfaro
, Emma Calabrese
, Maria Beatrice Principi
, Giuseppe Biscaglia
, Manuela Marzo
, Andrea Michielan
, Carolina Cavalli
, Annalisa Aratari
, Michele Campigotto
, Linda Ceccarelli
, Maria Cappello
, Simone Saibeni

Paola Balestrieri, Alessandra Soriano, Valentina Casini, Lorenzo Bertani, Brigida Barberio, Francesco Simone Conforti, Silvio Danese, Alessandro Armuzzi^*

^*Corresponding author

IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
Humanitas University
S. de Bellis National Institute of Gastroenterology
IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
University of Milan
University of Genoa
IRCCS Ospedale Sacro Cuore Don Calabria
Vita-Salute San Raffaele University
University of Rome Tor Vergata
University of Bari
IRCCS Ospedale Casa Sollievo della Sofferenza - San Giovanni Rotondo (FG)
UOC Gastroenterologia Ospedale Veris delli Ponti
Ospedale S. Chiara
Ospedale Civile, Pordenone
San Filippo Neri Hospital
University of Trieste
University of Pisa
University of Palermo
Ospedale di Rho
Universita Campus Bio-Medico di Roma
IRCCS Azienda Unità Sanitaria Locale di Reggio Emilia
Azienda Ospedaliera Bolognini Seriate
Tuscany Northwest ASL-Pontedera Hospital
University of Padua

Research output: Contribution to journal › Article

Abstract

Upadacitinib has recently been approved for treating Crohn's disease (CD). Here, we report on the effectiveness and safety of upadacitinib in a cohort of patients with diffcult-to-treat CD being cared for at clinical centers across Italy.

Original language	English
Pages (from-to)	N/A-N/A
Journal	CROHN’S & COLITIS 360
Volume	6
Issue number	4
DOIs	https://doi.org/10.1093/crocol/otae060
Publication status	Published - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Gastroenterology

Keywords

Crohn’s disease
difficult-to-treat IBD
effectiveness
remission
response
upadacitinib

Access to Document

10.1093/crocol/otae060

Cite this

Bezzio, C., Franchellucci, G., Savarino, E. V., Mastronardi, M., Caprioli, F. A., Bodini, G., Variola, A., Scaldaferri, F., Furfaro, F., Calabrese, E., Principi, M. B., Biscaglia, G., Marzo, M., Michielan, A., Cavalli, C., Aratari, A., Campigotto, M., Ceccarelli, L., Cappello, M., ... Armuzzi, A. (2024). Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease. CROHN’S & COLITIS 360, 6(4), N/A-N/A. https://doi.org/10.1093/crocol/otae060

@article{4cc55b449ca844edb39263681e19615d,

title = "Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease",

abstract = "Upadacitinib has recently been approved for treating Crohn's disease (CD). Here, we report on the effectiveness and safety of upadacitinib in a cohort of patients with diffcult-to-treat CD being cared for at clinical centers across Italy.",

keywords = "Crohn{\textquoteright}s disease, difficult-to-treat IBD, effectiveness, remission, response, upadacitinib, Crohn{\textquoteright}s disease, difficult-to-treat IBD, effectiveness, remission, response, upadacitinib",

author = "Cristina Bezzio and Gianluca Franchellucci and Savarino, \{Edoardo V\} and Mauro Mastronardi and Caprioli, \{Flavio Andrea\} and Giorgia Bodini and Angela Variola and Franco Scaldaferri and Federica Furfaro and Emma Calabrese and Principi, \{Maria Beatrice\} and Giuseppe Biscaglia and Manuela Marzo and Andrea Michielan and Carolina Cavalli and Annalisa Aratari and Michele Campigotto and Linda Ceccarelli and Maria Cappello and Simone Saibeni and Paola Balestrieri and Alessandra Soriano and Valentina Casini and Lorenzo Bertani and Brigida Barberio and Conforti, \{Francesco Simone\} and Silvio Danese and Alessandro Armuzzi",

year = "2024",

doi = "10.1093/crocol/otae060",

language = "English",

volume = "6",

pages = "N/A--N/A",

journal = "CROHN{\textquoteright}S \& COLITIS 360",

issn = "2631-827X",

number = "4",

}

Bezzio, C, Franchellucci, G, Savarino, EV, Mastronardi, M, Caprioli, FA, Bodini, G, Variola, A, Scaldaferri, F, Furfaro, F, Calabrese, E, Principi, MB, Biscaglia, G, Marzo, M, Michielan, A, Cavalli, C, Aratari, A, Campigotto, M, Ceccarelli, L, Cappello, M, Saibeni, S, Balestrieri, P, Soriano, A, Casini, V, Bertani, L, Barberio, B, Conforti, FS, Danese, S & Armuzzi, A 2024, 'Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease', CROHN’S & COLITIS 360, vol. 6, no. 4, pp. N/A-N/A. https://doi.org/10.1093/crocol/otae060

TY - JOUR

T1 - Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease

AU - Bezzio, Cristina

AU - Franchellucci, Gianluca

AU - Savarino, Edoardo V

AU - Mastronardi, Mauro

AU - Caprioli, Flavio Andrea

AU - Bodini, Giorgia

AU - Variola, Angela

AU - Scaldaferri, Franco

AU - Furfaro, Federica

AU - Calabrese, Emma

AU - Principi, Maria Beatrice

AU - Biscaglia, Giuseppe

AU - Marzo, Manuela

AU - Michielan, Andrea

AU - Cavalli, Carolina

AU - Aratari, Annalisa

AU - Campigotto, Michele

AU - Ceccarelli, Linda

AU - Cappello, Maria

AU - Saibeni, Simone

AU - Balestrieri, Paola

AU - Soriano, Alessandra

AU - Casini, Valentina

AU - Bertani, Lorenzo

AU - Barberio, Brigida

AU - Conforti, Francesco Simone

AU - Danese, Silvio

AU - Armuzzi, Alessandro

PY - 2024

Y1 - 2024

N2 - Upadacitinib has recently been approved for treating Crohn's disease (CD). Here, we report on the effectiveness and safety of upadacitinib in a cohort of patients with diffcult-to-treat CD being cared for at clinical centers across Italy.

AB - Upadacitinib has recently been approved for treating Crohn's disease (CD). Here, we report on the effectiveness and safety of upadacitinib in a cohort of patients with diffcult-to-treat CD being cared for at clinical centers across Italy.

KW - Crohn’s disease

KW - difficult-to-treat IBD

KW - effectiveness

KW - remission

KW - response

KW - upadacitinib

KW - Crohn’s disease

KW - difficult-to-treat IBD

KW - effectiveness

KW - remission

KW - response

KW - upadacitinib

UR - https://publicatt.unicatt.it/handle/10807/312372

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85209736661&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85209736661&origin=inward

U2 - 10.1093/crocol/otae060

DO - 10.1093/crocol/otae060

M3 - Article

SN - 2631-827X

VL - 6

SP - N/A-N/A

JO - CROHN’S & COLITIS 360

JF - CROHN’S & COLITIS 360

IS - 4

ER -

Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Keywords

Access to Document

Other files and links

Fingerprint

Cite this